Tesamorelin

Tesamorelin is a synthetic 44-amino-acid synthetic analogue of growth hormone-releasing hormone (GHRH), with an added trans-3-hexenoic acid group that increases its stability compared to native GHRH. It acts on the GHRH receptor in the anterior pituitary to stimulate endogenous GH secretion, and has been used in research contexts to study GHRH receptor pharmacology. Research has investigated Tesamorelin's pharmacokinetics in relation to GH pulse stimulation, its receptor binding characteristics, and how GHRH agonism influences downstream IGF-1 signalling in pre-clinical endocrine models. Tesamorelin has also been investigated in models examining visceral adipose tissue biology and lipid metabolism pathways.

Peptide

Tesamorelin

Strength

10 mg

Package

10 MG

Purity

≥99%

Form

vial